BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6315167)

  • 1. Monoaminergic antagonists which block naloxone-induced release of luteinizing hormone bind selectively to hypothalamic opiate receptors.
    Blank MS; Diez JA; Roberts DL
    Brain Res; 1983 Nov; 279(1-2):153-8. PubMed ID: 6315167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation of both adrenergic and opioidergic systems in the negative feedback of adrenal progesterone on LH secretion.
    Salicioni AM; Carón RW; Deis RP
    Eur J Pharmacol; 1997 Aug; 332(3):283-7. PubMed ID: 9300262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between prolactin and catecholamines on hypothalamic GnRH release in vitro.
    Calogero AE; Burrello N; Ossino AM; Weber RF; D'Agata R
    J Endocrinol; 1996 Nov; 151(2):269-75. PubMed ID: 8958787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of different opiates on hypothalamic monoamine turnover and on plasma LH levels in pro-oestrous rats.
    Gopalan C; Gilmore DP; Brown CH
    J Neurol Sci; 1989 Dec; 94(1-3):211-9. PubMed ID: 2559164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noradrenaline and prostaglandin E2 stimulate LH-RH release from rat median eminence through distinct 1-alpha-adrenergic and PGE2 receptors.
    Heaulme M; Dray F
    Neuroendocrinology; 1984 Nov; 39(5):403-7. PubMed ID: 6096749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro studies on the opioidergic control of the secretion of gonadotrophin-releasing hormone and luteinizing hormone in sexually immature and adult male rats.
    Leposavic G; Cover PO; Buckingham JC
    Neuroendocrinology; 1991 Jun; 53(6):579-88. PubMed ID: 1652110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone potentiation of novelty-induced hypoalgesia: characterization of the alpha-noradrenergic receptor subtype.
    Rochford J; Dawes P; Stewart J
    Pharmacol Biochem Behav; 1993 Feb; 44(2):381-6. PubMed ID: 8383341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the relationship between clonidine hypotension and brain beta-endorphin in the spontaneously hypertensive rat: studies with alpha adrenergic and opiate blockers.
    Mastrianni JA; Ingenito AJ
    J Pharmacol Exp Ther; 1987 Jul; 242(1):378-87. PubMed ID: 3039113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethanol inhibits the naloxone-induced release of luteinizing hormone-releasing hormone from the hypothalamus of the male rat.
    Cicero TJ; Newman KS; Gerrity M; Schmoeker PF; Bell RD
    Life Sci; 1982 Oct; 31(15):1587-96. PubMed ID: 6755122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. gamma-Aminobutyric acid-opioid interactions in the regulation of gonadotropin secretion in the immature female rat.
    Brann DW; Zamorano PL; Putnam-Roberts CD; Mahesh VB
    Neuroendocrinology; 1992 Oct; 56(4):445-52. PubMed ID: 1335551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between neuropeptide Y and adrenergic systems in the stimulation of luteinizing hormone release in steroid-primed ovariectomized rats.
    Allen LG; Crowley WR; Kalra SP
    Endocrinology; 1987 Dec; 121(6):1953-9. PubMed ID: 2824175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of catecholamine synthesis inhibitors and adrenergic receptor antagonists on restraint-induced LH release.
    Martín AI; Fernández-Ruiz J; López-Calderón A
    J Endocrinol; 1995 Mar; 144(3):511-5. PubMed ID: 7738475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in the responses of hypothalamic luteinizing hormone-releasing hormone and catecholamine systems to ovarian hormones and naloxone: implications for sexual differentiation of luteinizing hormone secretion in rats.
    Crowley WR
    Brain Res; 1988 Oct; 461(2):314-21. PubMed ID: 3052697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for noradrenergic involvement in naloxone-induced stimulation of luteinizing hormone release in prepubertal female rats.
    Koh T; Nakai Y; Kinoshita F; Tsujii S; Tsukada T; Imura H
    Eur J Pharmacol; 1983 May; 89(3-4):275-8. PubMed ID: 6307711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperprolactinemia decreases naloxone binding in the arcuate nucleus of ovariectomized rats.
    Weiland NG; Wise PM
    Neuroendocrinology; 1989 Dec; 50(6):667-72. PubMed ID: 2559342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of adrenergic antagonists on LH surge in short-term ovariectomized-steroids-primed rats.
    Pi WP
    Proc Natl Sci Counc Repub China B; 1999 Jul; 23(3):120-5. PubMed ID: 10492893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural circuits regulating pulsatile luteinizing hormone release in the female guinea-pig: opioid, adrenergic and serotonergic interactions.
    Gore AC; Terasawa E
    J Neuroendocrinol; 2001 Mar; 13(3):239-48. PubMed ID: 11207938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related differences in the sensitivity of serum luteinizing hormone to prototypic mu, kappa and delta opiate agonists and antagonists.
    Cicero TJ; Meyer ER; Miller BT; Bell RD
    J Pharmacol Exp Ther; 1988 Jul; 246(1):14-20. PubMed ID: 2839658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of luteinizing hormone release and catecholamine activity by opiates in the female rat.
    Adler BA; Crowley WR
    Neuroendocrinology; 1984 Mar; 38(3):248-53. PubMed ID: 6717750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate-induced enhancement of the effects of naloxone on serum luteinizing hormone levels in the male rat: specificity for Mu agonists.
    Cicero TJ; Owens DP; Schmoeker PF; Meyer ER
    J Pharmacol Exp Ther; 1983 Sep; 226(3):770-5. PubMed ID: 6310081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.